Views
3 years ago

Cardiopatía isquémica - Capítulo 5

  • Text
  • Nitratosysuuso
  • Ernestoylarri
  • Ivanrecabarren
  • Dosis
  • Luego
  • Tratamiento
  • Pacientes
  • Angina
  • Desarrollo
  • Tolerancia
  • Efectos
  • Efecto
  • Nitratos
Farmacología de los nitratos y su uso en cardiopatía isquémica. Ivan Recabarren, Ernesto Ylarri

EM Ylarri //

EM Ylarri // Farmacología Cardiovascular. De la molécula al paciente. Cardiopatía isquémica. • Gao X, Yang T, Liu M, et al. NADPH Oxidase in the Renal Microvasculature Is a Primary Target for Blood Pressure–Lowering Effects by Inorganic Nitrate and Nitrite; Hypertension. 2015; 65: 161-170. • Kardas P. Comparison of once daily versus twice daily oral nitrates in stable angina pectoris. Am J Cardiol. 2004; 94: 213–6. • Murrell W. Nitroglycerine as a remedy for angina pectoris. Lancet 1879; 113:225–7. • Münzel T, Daiber A, Gori T. Nitrate therapy: new aspects concerning molecular action and tolerance. Circulation 2011; 123: 2132-44. • Parker JD and Gori T. Tolerance to the Organic Nitrates; New Ideas, New Mechanisms, Continued Mystery, Circulation. 2001; 104: 2263-2265. • Steinhorn B, Loscalzo J, and Michel T. Nitroglycerin and Nitric Oxide — A Rondo of Themes in Cardiovascular Therapeutics, N Engl J Med 2015; 373: 277-280. • Stokes GS, Bune AJ, Huon N, Barin ES. Long term effectiveness of extended-release for the treatment of systolic hypertension. Hypertension. 2005; 45: 380–384. • Tarkin JM and Kaski JC. Vasodilator Therapy: Nitrates and Nicorandil. Cardiovasc Drugs Ther 2016; 30:367–378. • Taylor AL, Ziesche S, Yancy C, et al. African-American Heart Failure Trial Investigators. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med.2004;351:2049–2057. • Thadani U and Wittig T A. Randomized, Double- Blind, Placebo-Controlled, Crossover, Dose- Ranging Multicenter Study to Determine the Effect of Sublingual Nitroglycerin Spray on Exercise Capacity in Patients with Chronic Stable Angina; Clinical Medicine Insights: Cardiology 2012:6 87-95. • Thomas GR, DiFabio JM, Gori T, et al. Once Daily Therapy With Isosorbide-5-Mononitrate Causes Endothelial Dysfunction in Humans Evidence of a Free-Radical–Mediated Mechanism JACC 2007;49:1289–95. • Toda N and Okamura T. The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels, Pharmacological Reviews 2003;55:271-324. • Ural D, Kandemir AS, Karaüzüm K, et al. Effect of Oral Nitrates on All-Cause Mortality and Hospitalization in Heart Failure Patients with Reduced Ejection Fraction: A Propensity-Matched Analysis. Journal of Cardiac Failure 2017; 23:4, 286-292. • Watanabe H, Kakihana M, Ohtsuka S, et al. Preventive effects of carvedilol on nitrate toler- ance—a randomized, double-blind, placebo-controlled comparative study between carvedilol and arotinolol J Am Coll Cardiol Volume 32, Issue 5, 1 November 1998, Pages 1201–1206. • Zwinderman AH, Cleophas TJ, van der Sluijs H, Niemeyer MG, Buunk BP, van der Wall EE. Comparison of 50- mg and 100-mg sustained-release isosorbide mononitrate in the treatment of stable angina pectoris: effects on quality-of-life indices. Dutch mononitrate quality of life (DUMQOL) study group. Angiology. 1999; 50: 963–9. 78

Biblioteca

Av. García del Río 2585 Piso 12 A - C.A.B.A
+54 11 2092 1646 | info@sciens.com.ar

Editorial Sciens, Todos los Derechos Reservados 2015